Recruiting Atopic Dermatitis Studies in Berlin
A Study Evaluating ANV600 Single Agent or in Combination with Pembrolizumab in Participants with Advanced Solid Tumors (EXPAND-1)
The purpose of study ANV600-001 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, immunogenicity and antitumor activity of ANV600 administered as a single agent or ...
Study for AZD4360 in Participants With Advanced Solid Tumours
The purpose of this study is to evaluate the safety, tolerability, PK, immunogenicity, pharmacodynamics, and preliminary efficacy of AZD4360 in adult participants with locally advanced or metastatic s...
About Atopic Dermatitis Clinical Trials in Berlin
Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.
There are currently 2 atopic dermatitis clinical trials recruiting participants in Berlin, NEW%20JERSEY. These studies are seeking a combined 357 participants. Research is being sponsored by Anaveon AG, AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atopic Dermatitis Clinical Trials in Berlin — FAQ
Are there atopic dermatitis clinical trials in Berlin?
Yes, there are 2 atopic dermatitis clinical trials currently recruiting in Berlin, NEW%20JERSEY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Berlin?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Berlin research site will contact you about next steps.
Are clinical trials in Berlin free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Berlin studies also compensate for your time and travel.
What atopic dermatitis treatments are being tested?
The 2 active trials in Berlin are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.
Data updated March 2, 2026 from ClinicalTrials.gov